Cormorant Asset Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Cormorant Asset Management’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-130,000	Closed	-$18.5M	–	108
2020 Q3	$18.5M	Buy	130,000 +30,925	+31%	+$5.16M	0.71%	40
2020 Q2	$19.5M	Buy	99,075 +472	+0.5%	+$97.8K	0.74%	44
2020 Q1	$19.7M	Sell	98,603 -1,397	-1%	-$301K	0.91%	34
2019 Q4	$20.9M	Sell	100,000 -50,000	-33%	-$9.24M	0.83%	39
2019 Q3	$22.9M	Sell	150,000 -25,000	-14%	-$4.1M	1.39%	27
2019 Q2	$22.6M	Sell	175,000 -125,000	-42%	-$14.8M	1.3%	26
2019 Q1	$35M	Buy	+300,000	New	+$30.2M	2.36%	15
2017 Q3	–	Sell	-300,000	Closed	-$22.9M	–	59
2017 Q2	$22.9M	Hold	300,000	–	–	3.8%	6
2017 Q1	$26.1M	Sell	300,000 -34,044	-10%	-$2.45M	3.79%	4
2016 Q4	$21.4M	Hold	334,044	–	–	2.89%	11
2016 Q3	$21.4M	Hold	334,044	–	–	2.36%	14
2016 Q2	$18.3M	Buy	+334,044	New	+$16.8M	2.6%	12

Other funds holding LKFT

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Cormorant Asset Management's LKFT Position: Q4 2020 in Review

Cormorant Asset Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2020, closing a stake of 130,000 shares — an estimated $18.5M sold.

Cormorant Asset Management first reported a position in LKFT in Q2 2016 and held it in 12 quarters. The position peaked at $35M in Q1 2019. 116 funds tracked by Wall St. Rank hold LKFT as of Q4 2020.

Cormorant Asset Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2020 after selling out during the quarter.
Cormorant Asset Management sold 130,000 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2020, an estimated $18.5M.
Cormorant Asset Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2016 and held it in 12 quarters.
Cormorant Asset Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $35M in Q1 2019.
116 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2020.

Based on Cormorant Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.